2 false false false false false false false false false false true false false false false false false No description of principal activity 2024-11-01 Sage Accounts Production Advanced 2025 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 12955668 2024-11-01 2025-10-31 12955668 2025-10-31 12955668 2024-10-31 12955668 2023-11-01 2024-10-31 12955668 2024-10-31 12955668 2023-10-31 12955668 bus:Director1 2024-11-01 2025-10-31 12955668 core:WithinOneYear 2025-10-31 12955668 core:WithinOneYear 2024-10-31 12955668 bus:Micro-entities 2024-11-01 2025-10-31 12955668 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 12955668 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 12955668 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 12955668 bus:FullAccounts 2024-11-01 2025-10-31
COMPANY REGISTRATION NUMBER: 12955668
Skin Surgery Partnership Limited
Unaudited financial statements
31 October 2025
Skin Surgery Partnership Limited
Statement of financial position
31 October 2025
2025
2024
£
£
£
£
Fixed assets
816
1,607
----
------
Current assets
67,466
73,965
Creditors: amounts falling due within one year
( 220)
( 6,095)
-------
-------
Net current assets
67,246
67,870
-------
-------
Total assets less current liabilities
68,062
69,477
Accruals and deferred income
( 3,921)
( 3,984)
-------
-------
64,141
65,493
-------
-------
Capital and reserves
64,141
65,493
-------
-------
Notes to the financial statements
1. Employee numbers
The average number of employees during the year was 2 (2024: 2 ).
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 19 May 2026 , and are signed on behalf of the board by:
Dr J Garioch
Director
Company registration number: 12955668
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Bankside 300, Peachman Way, Broadland Business Park, Norwich, Norfolk, NR7 0LB, England.